A technique that transforms immune cells into cancer-seeking bloodhounds may overcome a roadblock that has hampered ...

A new approach engineers immune cells to recognize byproducts of cancer cells to trigger migration toward the tumor.

A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500 ...

CD8 + cytotoxic T lymphocytes (CTLs) serve as central effectors in cancer immunotherapy by directly eliminating tumor cells. However, current clinical therapies face significant limitations. These ...

Diffuse intrinsic pontine glioma (DIPG) is one of the most devastating pediatric brain tumors. It sits in the brainstem where it cannot be surgically removed, responds poorly to chemotherapy, and ...

Memory T cell therapy improves infection clearance after transplant, with 60% remission and strong safety outcomes in early ...

Immune cells are vigilant sentinels stationed at their tissue posts, such as the skin, lungs, or gut, or circulating in the bloodstream. Their presence and ability to quickly mobilize are key defenses ...